ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Angiotensin Converting Enzyme Inhibitor, Lisinopril, on Renal Blood Flow and Its Correlation With Proteinuria Reduction in Subjects With Type 2 Diabetes and Kidney Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01101269
Recruitment Status : Terminated (Slow Recruitment)
First Posted : April 9, 2010
Last Update Posted : May 12, 2017
Sponsor:
Information provided by (Responsible Party):
Kambiz Kalantarinia, University of Virginia

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : December 2014
  Actual Study Completion Date : December 2014